Scientists race to develop vaccine as Central African Ebola outbreak worsens

Health teams battling the Bundibugyo strain face shortages of equipment, rampant misinformation, and the absence of an approved vaccine. The Coalition for Epidemic Preparedness Innovations is underwriting the first clinical trials for an experimental shot, though manufacturing will not begin until later this year. Oxford University has also moved its vaccine into human testing. Officials warn the situation is rapidly turning into a humanitarian emergency.